These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15837566)
1. Molecular networks perturbed in a developmental animal model of brain injury. Kisby GE; Standley M; Lu X; O'Malley J; Lin B; Muniz J; Luo NL; Pattee P; Back SA; Nagalla SR Neurobiol Dis; 2005; 19(1-2):108-18. PubMed ID: 15837566 [TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum. Kisby GE; Standley M; Park T; Olivas A; Fei S; Jacob T; Reddy A; Lu X; Pattee P; Nagalla SR J Proteome Res; 2006 Oct; 5(10):2656-65. PubMed ID: 17022636 [TBL] [Abstract][Full Text] [Related]
3. Damage and repair of nerve cell DNA in toxic stress. Kisby GE; Kabel H; Hugon J; Spencer P Drug Metab Rev; 1999 Aug; 31(3):589-618. PubMed ID: 10461542 [TBL] [Abstract][Full Text] [Related]
4. The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. Kisby GE; Fry RC; Lasarev MR; Bammler TK; Beyer RP; Churchwell M; Doerge DR; Meira LB; Palmer VS; Ramos-Crawford AL; Ren X; Sullivan RC; Kavanagh TJ; Samson LD; Zarbl H; Spencer PS PLoS One; 2011; 6(6):e20911. PubMed ID: 21731631 [TBL] [Abstract][Full Text] [Related]
5. Genotoxicants target distinct molecular networks in neonatal neurons. Kisby GE; Olivas A; Standley M; Lu X; Pattee P; O'Malley J; Li X; Muniz J; Nagalla SR Environ Health Perspect; 2006 Nov; 114(11):1703-12. PubMed ID: 17107856 [TBL] [Abstract][Full Text] [Related]
6. Effects of single injection of methylazoxymethanol at postnatal day one on cell proliferation in different brain regions of male rats. Lu MH; Tang N; Ali SF Neurotoxicology; 2000 Dec; 21(6):1145-51. PubMed ID: 11233761 [TBL] [Abstract][Full Text] [Related]
7. Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol. Bassanini S; Hallene K; Battaglia G; Finardi A; Santaguida S; Cipolla M; Janigro D Neurobiol Dis; 2007 May; 26(2):481-95. PubMed ID: 17398107 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice. Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124 [TBL] [Abstract][Full Text] [Related]
9. Different effect of methylazoxymethanol on mouse cerebellar development depending on the age of injection. Bejar A; Roujansky P; de Barry J; Gombos G Exp Brain Res; 1985; 57(2):279-85. PubMed ID: 3972031 [TBL] [Abstract][Full Text] [Related]
10. Postnatal methylazoxymethanol: sensitive periods and regional selectivity of effects. Sullivan-Jones P; Ali SF; Gough B; Holson RR Neurotoxicol Teratol; 1994; 16(6):631-7. PubMed ID: 7862061 [TBL] [Abstract][Full Text] [Related]
11. Disruption of cerebellar maturation by an antimitotic agent impairs the ontogeny of eyeblink conditioning in rats. Freeman JH; Barone S; Stanton ME J Neurosci; 1995 Nov; 15(11):7301-14. PubMed ID: 7472484 [TBL] [Abstract][Full Text] [Related]
12. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437 [TBL] [Abstract][Full Text] [Related]
13. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031 [TBL] [Abstract][Full Text] [Related]
15. Methylazoxymethanol as a developmental model of neurotoxicity. Kabat K; Buterbaugh GG; Eccles CU Neurobehav Toxicol Teratol; 1985; 7(5):519-25. PubMed ID: 4080069 [TBL] [Abstract][Full Text] [Related]
16. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease. Kisby GE; Spencer PS Front Neurosci; 2021; 15():752153. PubMed ID: 34924930 [TBL] [Abstract][Full Text] [Related]
17. Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. Sieber SM; Correa P; Dalgard DW; McIntire KR; Adamson RH J Natl Cancer Inst; 1980 Jul; 65(1):177-89. PubMed ID: 6248673 [TBL] [Abstract][Full Text] [Related]
18. Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia. Paredes M; Pleasure SJ; Baraban SC J Comp Neurol; 2006 Mar; 495(1):133-48. PubMed ID: 16432901 [TBL] [Abstract][Full Text] [Related]
19. Tumor induction in germfree rats with methylazoxymethanol (MAM) and synthetic MAM acetate. Laqueur GL; McDaniel EG; Matsumoto H J Natl Cancer Inst; 1967 Aug; 39(2):355-71. PubMed ID: 18623950 [TBL] [Abstract][Full Text] [Related]
20. Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia. Chin CL; Curzon P; Schwartz AJ; O'Connor EM; Rueter LE; Fox GB; Day M; Basso AM Synapse; 2011 May; 65(5):393-403. PubMed ID: 20803618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]